Qiongli Z. Zhai

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups

Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 21, 2026

Correction: Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.

Correction: Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.

Journal: Stem cell research & therapy

Published: April 17, 2025

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Journal: The Journal of clinical investigation

Published: March 17, 2025

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Journal: Research square

Published: January 27, 2025

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Journal: Blood cancer journal

Published: January 24, 2025

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.

Journal: The Journal of clinical investigation

Published: May 15, 2024

RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling.

RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling.

Journal: Acta histochemica

Published: March 15, 2024

Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis.

Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: February 13, 2024

Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.

Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.

Journal: Annals of diagnostic pathology

Published: September 29, 2023

Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells.

Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: December 06, 2022

Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.

Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.

Journal: Chemical biology & drug design

Published: July 14, 2022

Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.

Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.

Journal: American journal of cancer research

Published: June 07, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026